SCPH
scPharmaceuticals
SCPH
SCPH
Delisted
SCPH was delisted on the 6th of October, 2025.
40 hedge funds and large institutions have $60M invested in scPharmaceuticals in 2022 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 9 increasing their positions, 15 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
6.17% less ownership
Funds ownership: 57.34% → 51.18% (-6.2%)
40% less repeat investments, than reductions
Existing positions increased: 9 | Existing positions reduced: 15
Holders
40
Holding in Top 10
1
Calls
$131K
Puts
$82K
Top Buyers
| 1 | +$330K | |
| 2 | +$167K | |
| 3 | +$148K | |
| 4 |
RWM
Ritholtz Wealth Management
New York
|
+$98K |
| 5 |
Envestnet Asset Management
Chicago,
Illinois
|
+$92K |
Top Sellers
| 1 | -$3.84M | |
| 2 | -$2.64M | |
| 3 | -$1.48M | |
| 4 |
AC
Armistice Capital
New York
|
-$1.36M |
| 5 |
WVP
Worth Venture Partners
Fort Lee,
New Jersey
|
-$961K |